Researchers discuss disrupting NKG2A:HLA-E interactions for enhanced anti-cancer immunity
A new editorial titled "Strategies to disrupt NKG2A:HLA-E interactions for improved anti-cancer immunity" has been published in Oncotarget.
Aug 21, 2024
0
46
MeSH tree: D09.400.430.890.489.850
A new editorial titled "Strategies to disrupt NKG2A:HLA-E interactions for improved anti-cancer immunity" has been published in Oncotarget.
Aug 21, 2024
0
46
Conventional wisdom lays out two major roles for the major histocompatibility complex (MHC): Class I MHC (MHC-I) displays peptide fragments of proteins from within the cell on the cell surface and elicits a response from ...
Oct 12, 2023
0
79
An obscure class of molecules, part of the vast system that helps the human body distinguish "self" from "non-self," may also hold the key to stopping SARS-CoV-2 from commandeering healthy cells, scientists have found in ...
Medical science has not yet been able to explain why the Epstein-Barr virus triggers infectious mononucleosis (IM) in some people with initial infections and not in others. But now, a research team led by Elisabeth Puchhammer-Stöckl, ...
Jan 19, 2023
0
129
Mount Sinai researchers have made two important discoveries about the mechanism by which bladder cancer cells foil attacks from the immune system. The research, published in Cancer Cell in September, could lead to a new therapeutic ...
Sep 12, 2022
0
67